Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin in mild COVID-19 patients
NCT04739410Phase 4Completed
- Sponsor
- FMH College of Medicine and Dentistry
- Start
- May 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of CHILD-IVITAB in coronavirus disease 2019 (COVID-19), sponsored by FMH College of Medicine and Dentistry. Started May 2020; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04739410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04739410.